Ophthalmic Business News

As baby boomers age into their 70s and 80s, it is estimated that more than $84 trillion will pass down through inheritances to millennial and Gen X heirs before 2045.

Oh my. Another FDA recall of generic artificial tears hit the news during eyeball month.

SAN FRANCISCO — In this Healio Video Perspective from Eyecelerator@AAO, Richard A. Lewis, MD, of ViaLase discusses femtosecond laser image-guided high-precision trabeculotomy for the treatment of glaucoma.

The FDA issued a complete response letter regarding the new drug application for reproxalap for the treatment of dry eye disease, according to a press release from Aldeyra Therapeutics.

SAN FRANCISCO — In this Healio Video Perspective from the AAO meeting, Jeff Todd, JD, president and CEO of Prevent Blindness, discusses the Gr8 Eye Movement, a campaign to bring awareness to diabetes-related eye disease.

I am supportive of Healio | OSN’s decision to bring the Residency to Retirement series focused on financial planning to our readers.

SAN FRANCISCO — In this Healio Video Perspective from the AAO meeting, John Sheets, PhD, of Pantheon Vision, discusses the launch of the company and its goal of combatting corneal blindness globally.

SAN FRANCISCO — In this Healio Video Perspective from Eyecelerator@AAO, Mariam Maghribi of Atia Vision and Shifamed, delivers updates from each company including developments for the OmniVu IOL system.

SAN FRANCISCO — In this Healio Video Perspective from the AAO meeting, Rajesh K. Rajpal, MD, chief medical officer at Johnson & Johnson Vision, discusses the company’s latest developments.

In this episode, Cathleen McCabe, MD, and Laura Enyedi, MD, chat with guest Cindy Toth, MD, about her career as a female surgeon in the field of ophthalmology.